SCHEMBL687796

SCHEMBL687796

Cc1cn(Cc2ccccc2Cl)c(=O)c(NC(=O)N[C@@H](CC(=O)O)c2cccc(C(F)(F)F)c2)c1O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CTSA P10619 3/20 0.46
MAPT P10636 2/20 0.40
THRB P10828 1/20 0.40
PTGER3 P43115 6/20 0.39
WDR5 P61964 2/20 0.39
DCUN1D1 Q96GG9 1/20 0.39
IL1B P01584 1/20 0.38
P2RX7 Q99572 1/20 0.38
TP53 P04637 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
CNR2 P34972 1/20 0.37
SLC22A12 Q96S37 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688442 0.90 PTGER3 (0.42) CTSAMAPTPTGER3TP53RXFP1
SCHEMBL687045 0.90 PTGER3 (0.42) CTSAMAPTPTGER3CNR2SLC22A12
SCHEMBL687348 0.90 PTGER3 (0.41) CTSAMAPTTHRBPTGER3TP53
SCHEMBL688053 0.90 PTGER3 (0.43) CTSAMAPTPTGER3TP53ALDH1A1
SCHEMBL687873 0.89 PTGER3 (0.42) MAPTPTGER3WDR5CNR2SLC22A12
SCHEMBL687991 0.88 GNRHR (0.38) CTSAPTGER3CNR2
SCHEMBL686799 0.88 PTGER3 (0.51) CTSAMAPTTHRBPTGER3CNR2
SCHEMBL688170 0.87 PTGER3 (0.41) MAPTPTGER3TP53ALDH1A1RXFP1
SCHEMBL686986 0.87 MEN1 (0.42) CTSAMAPTPTGER3TP53MEN1
SCHEMBL687712 0.87 PTGER3 (0.43) CTSAMAPTPTGER3KMT2ACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed